Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
12/2005
12/14/2005CN1231440C Novel tricyclic compound
12/14/2005CN1231431C Process for preparing substituted 2-3-dihydro-1-indanones
12/13/2005US6974876 Method for preparing intermediates useful in synthesis of retroviral protease inhibitors
12/13/2005US6974806 Preventing or treating acute myocardial infarction, unstable angina and peripheral artery occlusion
12/13/2005US6974802 Treatment of viral infections using prodrugs of 2′,3-dideoxy,3′-fluoroguanosine
12/08/2005WO2005116111A1 Method for producing elastomeric copolyesters
12/08/2005WO2005115983A1 Aryl sulfonamide and sulfonyl compounds as modulators of ppar and methods of treating metabolic disorders
12/08/2005WO2005115972A1 Therapeutic compounds
12/08/2005WO2005097100A3 Antibacterial agents
12/08/2005WO2005082350A8 Furosemide derivatives as modulators of hm74 and their use for the treatment of inflammation
12/08/2005WO2005077926A3 Benzofuran and benzothiophene derivatives useful for the treatment of cardiovascular disease
12/08/2005WO2005034940A3 Dual alanyl aminopeptidase and dipeptidyl peptidase iv inhibitors for functionally influencing different cells and for treating immunological, inflammatory, neuronal and other diseases
12/08/2005US20050272943 Process for preparing prostaglandin derivatives and starting materials for the same
12/08/2005US20050272931 Vanilloid receptor ligands and their use in treatments
12/08/2005US20050272877 Process for the preparation of prostaglandins and analogues thereof
12/08/2005US20050272777 Vanilloid receptor ligands and their use in treatments
12/08/2005US20050272718 Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes
12/08/2005US20050272704 Compounds, compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding
12/08/2005US20050272036 Ketones
12/08/2005DE102004023105A1 Verfahren zur Herstellung von elastomeren Copolyestern A process for the preparation of elastomeric copolyesters
12/08/2005CA2565066A1 Therapeutic compounds
12/08/2005CA2564638A1 Aryl sulfonamide and sulfonyl compounds as modulators of ppar and methods of treating metabolic disorders
12/07/2005EP1602642A1 Imino ether derivative compounds and drugs containing the compounds as the active ingredient
12/07/2005EP1601662A1 Process for the preparation of a cyano-isobenzofuran
12/07/2005EP1077928B1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
12/07/2005EP1077927B1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
12/07/2005EP0981523B1 Cyclic ether vitamin d3 compounds, 1alpha (oh) 3-epi-vitamin d3 compounds and uses thereof
12/07/2005CN1705659A Large conductance calcium-activated k channel opener
12/07/2005CN1705654A Methods for treating depression and other cns disorders using enantiomerically enriched desmethyl-and didesmethyl-metabolites of citalopram
12/07/2005CN1705653A 3-(cyclopenten-1-yl)-benzyl- or 3-(cyclopenten-1-yl)-heteroarylmethyl-amine derivatives and use thereof as medicines for treating schizophrenia
12/07/2005CN1705647A Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
12/07/2005CN1705478A Novel compounds, pharmaceutical compositions containing same, and methods of use for same
12/07/2005CN1704411A Process for preparing furfuryl amine with nano nickel as catalyst
12/07/2005CN1704404A Tricyclic protein kinase inhibitors
12/07/2005CN1230429C Process for producing ascorbic acid in presence of sulfite
12/06/2005US6972294 Compounds, their preparation and use
12/06/2005US6972290 Piperazine derivatives and their use as anti-inflammatory agents
12/06/2005CA2303244C Cyclic amino acids and derivatives thereof useful as pharmaceutical agents
12/06/2005CA2096528C Retroviral protease inhibitors
12/01/2005WO2005113531A1 Light-emitting device material and light-emitting device
12/01/2005WO2005113530A1 Process for producing optically active citalopram and intermediate of said citalopram
12/01/2005WO2005113529A2 Novel cylopenta[b]benzofuran derivatives and the utilization thereof
12/01/2005WO2005113523A1 2-((hetero) aryl)-benzoxazole compounds and derivatives, compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding
12/01/2005WO2005113506A1 Compounds and compositions as ppar modulators
12/01/2005WO2005112945A2 Synthesis of tetracyclines and analogues thereof
12/01/2005WO2005112913A1 Transthyretin stabilization
12/01/2005WO2005112640A2 Compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases
12/01/2005WO2005077899A3 Amino-substituted tricyclic derivatives and methods of use
12/01/2005WO2005060456A3 Method for treating adamts-5-associate disease
12/01/2005US20050267199 2-Amino- and 2-thio- substituted 1,3-diaminopropanes
12/01/2005US20050267190 Solid-state form of celecoxib having enhanced bioavailability
12/01/2005US20050267173 Serine protease inhibitors
12/01/2005US20050267171 Alpha-and beta-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
12/01/2005US20050267163 Vanilloid receptor ligands and their use in treatments
12/01/2005US20050267149 Benzoic acid derivatives as modulators of ppar alpha and gamma
12/01/2005US20050267126 Compounds derived from aryl carbamates, preparation thereof and uses of same
12/01/2005US20050267123 6-Membered heterocyclic compounds useful for selective inhibition of the coagulation cascade
12/01/2005US20050266351 a copolymer of an adamantanecarbonyloxyalkyl acrylic acid ester and a 2-furanone ester of acrylc acid; acid generator is triphenylsulfonium 1-(3-hydroxymethyl-adamantane)methoxycarbonyldifluoromethanesulfonate or triphenylsulfonium 4-oxo-1-adamantyloxycarbonyldifluoromethanesulfonate;
12/01/2005CA2567404A1 Cyclopenta[b]benzofuran derivatives and the utilization thereof
12/01/2005CA2566923A1 2-((hetero) aryl)-benzoxazole compounds and derivatives, compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding
12/01/2005CA2566688A1 Transthyretin stabilization
12/01/2005CA2564365A1 Compounds and compositions as ppar modulators
11/2005
11/30/2005EP1599458A1 Method for preparing oxydiphthalic anhydrides using bicarbonate as catalyst
11/30/2005EP1529039B1 Method for producing maleic anhydride
11/30/2005EP1159278B1 Inhibitors of aspartyl protease
11/30/2005EP1098864B9 Method for hydrogenating unsaturated heterocyclic compounds
11/30/2005EP1091943B1 Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
11/30/2005EP0925291B1 Spirocyclic dopamine receptor subtype ligands
11/30/2005CN1703395A Aryl and heteroaryl compounds and methods to modulate coagulation
11/30/2005CN1229491C Method for microbial regulation
11/30/2005CN1229367C Furan 4alpha-methylol polyhydro naphthalene compound and its synthesis and use
11/30/2005CN1229366C Methanesulphonamido-benzofuran derivative, preparation method and use thereof as synthesis ntermediate
11/30/2005CN1229365C Method for distillative separation of mixtures containing tetrahydrofuran, gamma-butyrolactone and/or 1,4-butanediol
11/30/2005CN1229362C Bicyclic guanidine derivatives and therapeutic uses thereof
11/30/2005CN1229324C Extraction process of tanshin general phenolic acid and its prepn and use
11/30/2005CN1229323C Dialkoyl-halogen phenyl substituted keto-enol
11/29/2005US6969770 reacting an alpha-keto carboxy acid ester or derivative with a pyrrolidinone to form an intermediate, subjecting the intermediate to asymmetric hydrogenation using a chiral catalyst to form the end product
11/29/2005US6969731 Protease inhibitors that overcome drug resistance
11/29/2005US6969730 Amines as histamine-3 receptor ligands and their therapeutic applications
11/29/2005US6969715 6-membered heterocyclic compounds useful for selective inhibition of the coagulation cascade
11/29/2005CA2244245C Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
11/24/2005WO2005111010A1 An improved process for the preparation of 5-cyanophthalide
11/24/2005WO2005110971A1 Heteroaryl substituted cyclohexyl-1,4-diamine derivatives
11/24/2005WO2005090296A3 N-substituted benzene sulfonamides
11/24/2005US20050261507 Preparation of stereoisomers of (3alpha/beta, 6alpha/beta)hexahydrofuro[2,3-b]furan-3-ol
11/24/2005US20050261374 Process for the preparation of prostaglandins and analogues thereof
11/24/2005US20050261365 Transthyretin stabilization
11/24/2005US20050261347 Dihydrobenzofuranyl alkanamine derivatives and methods for using same
11/24/2005US20050261345 beta-amyloid antiaggregating properties; 2,5-Bis-{6-[ethyl-(2-methoxy-benzyl)-amino]-hexylamino}-[1,4]benzoquinone for example
11/24/2005US20050261301 e,g, 1,5-bis(5-acetyl-4,7-dimethoxybenzofuran-6-yloxy)pentane;potassium channel modulator; antiinflammatory agent, autoimmune diseases; immunosuppressant; multiple sclerosis, rejection of foreign organ transplants
11/24/2005US20050261291 1-Cyclopropylmethyl-4-[2-(3,3,5,5-tetramethylcyclohexyl)phenyl]piperazine or a salt or hydrate; exhibit excellent cell adhesion inhibitory action or cell infiltration inhibitory action; for treating inflammatory diseases and autoimmune diseases such as inflammatory bowel diseases and rheumatoid arthritis
11/24/2005US20050261273 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors
11/24/2005US20050260126 Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein
11/24/2005US20050258553 Method for the organometallic production of organic intermediate products comprising carbon-heteroatom bonds achieved by the deprotonation of heteroatoms
11/24/2005US20050258399 Electrooptic display
11/24/2005US20050258025 Water-containing tetrahydrofuran is purified by passing through three distillation columns, withdrawing water from first column, recycling water-containing tetrahydrofuran from top of second column into the first column, passing a sidestream of the first column into second column, recycling the
11/24/2005DE102004021691A1 Fluorierte Heterocyclen und ihre Verwendung in Flüssigkristallmischungen Fluorinated heterocyclic compounds and their use in liquid crystal mixtures
11/24/2005CA2566212A1 Heteroaryl-substituted cyclohexyl-1,4-diamine derivatives
11/23/2005EP1598067A1 Carbamic acid compounds comprising an amide linkage as HDAC inhibitors
11/23/2005EP1597248A2 Sulfonamide derivatives as ppar modulators
1 ... 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 ... 472